Prostate Cancer

by Charles R. Thomas Jr. MD (Editor)

Overview

This issue of Radiation Medicine Rounds examines the latest advances in the use of radiation medicine in treatment of prostate cancer Prostate cancer is the most common cancer in males and radiation therapy is a major tool in the management of the disease. This issue of Radiation Medicine Rounds includes reviews of all major recent advances in treatment of favorable, intermediate and high-risk prostate cancer as well as newer modalities such as brachytherapy, stereotactic body radiation therapy, and proton beam radiotherapy. Articles also review current knowledge in the areas of new biomarkers, risk stratification, and risk stratification. This issue of RMR will provide the practitioner with a full current overview of the present best practices and recent research in management of this complex and challenging disease.

Radiation Medicine Rounds features:

• In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Radiation Medicine
• Each issue edited by an authority in that subject area
• Each issue focused on a single major topic in Radiation Medicine, providing coverage of advances in radiation science, radiation medicine technology, radiation medicine practice, and assessment of recent quality and outcome studies

Product Details

ISBN-13:	9781617050671
Publisher:	Springer Publishing Company
Publication date:	04/12/2011
Series:	Radiation Medicine Rounds , #1
Sold by:	Barnes & Noble
Format:	eBook
Pages:	120
File size:	3 MB

About the Author

Allen M. Chen, MD, Assistant Professor and Director, Residency and Fellowship Training Program, Department of Radiation Oncology, UC Davis Medical Center

Charles R. Thomas, Jr., MD is Professor and Chairman of the Department of Radiation Medicine and Professor of Hematology/Oncology at the Oregon Health&Science University Cancer Institute.

Srinivasan Vijayakumar, MD, Department Chair and Professor, Department of Radiation Oncology, University of Mississippi Medical Center

Table of Contents

1.New Biomarkers in Prostate Cancer: A Radiation Oncology Perspective 2. Risk Stratification in Nonmetastatic Prostate Cancer: Implications for Treatment, 3. Treatment of Favorable- Risk Prostate Cancer, 4. Intermediate Risk Prostate Cancer: Role of Androgen Deprivation, 5. High-Risk Prostate Cancer 6 Duration and Timing of Neoadjuvant/Adjuvant Androgen Deprivation in Nonmetastatic Prostate Caner, 7. Current Role of Salvage and Adjuvant Radiotherapy for Prostate Cancer, 8. Prostate Brachytherapy, 9. Stereotactic Body Radiation for Prostate Cancer, 10. Proton Therapy for the Treatment of Prostate Cancer, 11. Image-Guided Strategies for Prostate Cancer, 12. Treatment of Intermediate-Risk Prostate Cancer , 13. Chemoprevention in Prostate Cancer: Current Clinical Evidence, 14. Quality-of-Life Issues in the Radiotherapeutic Management of Localized Prostate Cancer

Editorial Reviews

Reviewer: Mark Buyyounouski, MD, MS (Fox Chase Cancer Center)
Description: This is a current and comprehensive description of prostate cancer, ranging from prevention and screening to local and novel therapies for all stages of disease. The chapters are well written by some of the most recognized names in the field.
Purpose: The authors present focused chapters on key areas of current practice, controversy, and research in the treatment of patients with prostate cancer. The in-depth reviews offer a high level of detail that is stimulating and enriching without being overwhelming.
Audience: The book is ideal for prostate cancer specialists who are interested in keeping current in the practices and developments in the fields of radiation, medical, and surgical oncology. With chapter topics such as an update of androgen deprivation therapy for advanced prostate cancer and the current state of docetaxel-based therapy in castration-resistant prostate cancer, it is also an excellent, clinically based review for nonspecialists.
Features: There is a greater focus on medical management in this book, but the discussions of surgical and radiation approaches for clinically localized disease are thorough. Noteworthy chapters discuss emerging medical treatments such as immunotherapy and novel androgen and bone-targeted therapies.
Assessment: This is a well-written, concise, and current review of prostate cancer treatment that should appeal to all practitioners. It is a great resource for balanced perspectives on current concepts and treatments for all stages of the disease.

Doody's Review Service